糖酵解
癌症研究
安普克
转移
己糖激酶
基因敲除
生物
厌氧糖酵解
蛋白激酶A
内科学
内分泌学
激酶
癌症
细胞生物学
医学
新陈代谢
生物化学
基因
作者
Yang‐Hsiang Lin,Meng‐Han Wu,Ya‐Hui Huang,Chau–Ting Yeh,Mei‐Ling Cheng,Hsiang‐Cheng Chi,Chung‐Ying Tsai,I‐Hsiao Chung,Ching‐Ying Chen,Kwang‐Huei Lin
出处
期刊:Hepatology
[Wiley]
日期:2017-08-12
卷期号:67 (1): 188-203
被引量:139
摘要
Cancer cells display altered glucose metabolism characterized by a preference for aerobic glycolysis. The aerobic glycolytic phenotype of hepatocellular carcinoma (HCC) is often correlated with tumor progression and poorer clinical outcomes. However, the issue of whether glycolytic metabolism influences metastasis in HCC remains unclear. In the current study, we showed that knockdown of taurine up‐regulated gene 1 ( TUG1 ) induces marked inhibition of cell migration, invasion, and glycolysis through suppression of microRNA (miR)‐455‐3p. MiR‐455‐3p, which is transcriptionally repressed by p21, directly targets the 3′ untranslated region of adenosine monophosphate‐activated protein kinase subunit beta 2 (AMPKβ2). The TUG1/miR‐455‐3p/AMPKβ2 axis regulates cell growth, metastasis, and glycolysis through regulation of hexokinase 2 (HK2). TUG1 is clearly associated with HK2 overexpression and unfavorable prognosis in HCC patients. Conclusion : Our data collectively highlight that novel regulatory associations among TUG1, miR‐455‐3p, AMPKβ2, and HK2 are an important determinant of glycolytic metabolism and metastasis in HCC cells and support the potential utility of targeting TUG1/HK2 as a therapeutic strategy for HCC. (H epatology 2018;67:188‐203)
科研通智能强力驱动
Strongly Powered by AbleSci AI